Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
Analgesia Nociceptive Index for Nociception Monitoring in Cirrhotic Patients Undergoing Hepatic Resection: Randomized Control Trial
Nitazoxanide and Lansoprazole Based Regimens for Managing Helicobacter Pylori in Egyptian Patients (NILE Study)
The study will evaluate the eradication rate and tolerability of modified LOAD regimens (three antibiotics and a proton pump inhibitor (lansoprazole)) for management of HP infection in treatment-naive patients as well as patients who failed previous therapies.
Inappropriate Use of Proton Pump Inhibitors in Patients With Liver Cirrhosis
Proton pump inhibitors (PPIs) inappropriate use, in patients with cirrhosis, presents a significant clinical challenge. This study evaluates overprescription and misuse of PPIs in cirrhotic patients. The patterns of use of PPIs will be classified into two groups based on adherence to the proven indications: Group A: Inappropriate use of PPI, Group B: Appropriate use of PPI. We will estimate the prevalence of PPI misuse in cirrhotics and correlate it with different factors.
100 Clinical Results associated with National Liver Institute, Egypt
0 Patents (Medical) associated with National Liver Institute, Egypt
100 Deals associated with National Liver Institute, Egypt
100 Translational Medicine associated with National Liver Institute, Egypt